Factors Affecting Postoperative Recurrence in Patients with Pathological Stage IB Non-small-cell Lung Cancer
暂无分享,去创建一个
T. Mitsudomi | M. Shinoda | T. Fukui | F. Ishiguro | K. Okuda | S. Hatooka | N. Sakakura | T. Katayama | S. Mori
[1] Julio Astudillo,et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. , 2006, The Lancet. Oncology.
[2] G. Scagliotti,et al. Lung Adjuvant Cisplatin Evaluation (LACE): A pooled analysis of five randomized clinical trials including 4,584 patients. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] D. Sugarbaker,et al. Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): Update of Cancer and Leukemia Group B (CALGB) protocol 9633. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] D. Giannarelli,et al. Treatment of resected non-small-cell lung cancer. , 2005, The New England journal of medicine.
[5] H. Wada,et al. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Robert Livingston,et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. , 2005, The New England journal of medicine.
[7] R. Schilsky,et al. Randomized Clinical Trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB Non-Small Cell Lung Cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] H. Kato,et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. , 2004, The New England journal of medicine.
[9] Bengt Bergman,et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. , 2004, The New England journal of medicine.
[10] G. Giaccone,et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer. , 2003, Journal of the National Cancer Institute.
[11] M. Oda,et al. Proposals regarding some deficiencies in the new international staging system for non-small cell lung cancer. , 1991, Japanese journal of clinical oncology.
[12] M. Noguchi,et al. Clinicopathologic characteristics of adenosquamous carcinoma of the lung , 1991, Cancer.
[13] M. Haniuda,et al. Assessment of Neoplasm Staging for Pathologic Stage I Non-small Cell Lung Cancer Using Postoperative Results. , 2001 .